Machina Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Machina Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Buy	+1,033	New	+$226K	0.04%	345
2023 Q4	–	Sell	-2,380	Closed	-$308K	–	303
2023 Q3	$308K	Buy	+2,380	New	+$317K	0.17%	203
2020 Q1	–	Sell	-3,235	Closed	-$483K	–	146
2019 Q4	$483K	Buy	3,235 +1,660	+105%	+$226K	0.19%	190
2019 Q3	$202K	Buy	1,575 +1,374	+684%	+$184K	0.09%	288
2019 Q2	$29K	Buy	+201	New	+$27K	0.01%	434

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Machina Capital's JAZZ Position: Q2 2026 in Review

Machina Capital opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,033 shares worth $249K. The stake represents 0.04% of the portfolio and ranks #345 among its holdings. This is a return to the name: Machina Capital previously reported a position in JAZZ as recently as Q3 2023.

Machina Capital first reported a position in JAZZ in Q2 2019 and has held it in 5 quarters since. The position peaked at $483K in Q4 2019. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Machina Capital held 1,033 shares of Jazz Pharmaceuticals worth $249K as of Q2 2026.
Jazz Pharmaceuticals was a new Machina Capital position in Q2 2026.
Jazz Pharmaceuticals made up 0.04% of Machina Capital's portfolio in Q2 2026, its #345 holding.
Machina Capital first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
Machina Capital's Jazz Pharmaceuticals position peaked at $483K in Q4 2019.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.